{
    "title": "AstraZeneca to buy US biotech firm and its experimental blood cancer drug in deal worth up to \u00a3990m",
    "url": "https://www.dailymail.co.uk/money/markets/article-10982757/AstraZeneca-agrees-deal-worth-990m-purchase-biotech-firm.html",
    "date": "2022-07-05",
    "keywords": [
        "astrazeneca",
        "blood",
        "year",
        "company",
        "haematology",
        "drug",
        "share",
        "cent",
        "fund",
        "giant",
        "teneotwo",
        "cancer",
        "rd",
        "part",
        "tcell",
        "treatment",
        "investment",
        "account",
        "fee",
        "biotechnology",
        "deal",
        "pipeline",
        "purchasing",
        "lymphomait",
        "companys",
        "equity",
        "milestone",
        "research",
        "development",
        "performance",
        "acquisition",
        "lymphomacompletion",
        "takeover",
        "quarter",
        "approval",
        "outlook",
        "yearteneotwo",
        "biotech",
        "firm",
        "teneobio",
        "amgen",
        "antibody",
        "engager",
        "immune",
        "system",
        "demand",
        "vaccine",
        "boss",
        "knighthood",
        "pharma",
        "step",
        "article",
        "moment",
        "phase",
        "trial",
        "bcell",
        "lymphoma",
        "treatmentthis",
        "study",
        "june",
        "vice",
        "president",
        "therapy",
        "patient",
        "molecule",
        "window",
        "activation",
        "potential",
        "care",
        "setting",
        "tn486",
        "group",
        "portfolio",
        "calquence",
        "lymphomacalquence",
        "astrazenecas",
        "buying",
        "alexion",
        "specialist",
        "collection",
        "treat",
        "disease",
        "kidney",
        "condition",
        "syndromeastrazeneca",
        "value",
        "capital",
        "risk",
        "isa",
        "trade",
        "month",
        "community",
        "model",
        "affiliate",
        "product",
        "money",
        "commission",
        "editorial",
        "independence",
        "investing"
    ],
    "category": [
        "money",
        "markets"
    ]
}